Merck (MRK) EBIT Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
80.35% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
2.93% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
6.88% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-411.15% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
126.32% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
15.60% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
-0.98% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
-193.55% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-411.15% |
| Dec 31, 2025 |
-723.10% |
| Sep 30, 2025 |
28,800.00% |
| Jun 30, 2025 |
-36.22% |
| Mar 31, 2025 |
16.62% |
| Dec 31, 2024 |
105.74% |
| Sep 30, 2024 |
-99.26% |
| Jun 30, 2024 |
124.16% |
| Mar 31, 2024 |
871.74% |
| Dec 31, 2023 |
-1,519.02% |
| Sep 30, 2023 |
486.32% |
| Jun 30, 2023 |
-3,553.51% |
| Mar 31, 2023 |
46.82% |
| Dec 31, 2022 |
-1,151.43% |
| Sep 30, 2022 |
-119.33% |
| Jun 30, 2022 |
119.54% |
| Mar 31, 2022 |
-144.81% |
| Dec 31, 2021 |
100.46% |
| Sep 30, 2021 |
691.53% |
| Jun 30, 2021 |
-23,016.67% |
| Mar 31, 2021 |
-140.30% |
| Dec 31, 2020 |
-146.31% |
| Sep 30, 2020 |
81.31% |
| Jun 30, 2020 |
95.77% |
| Mar 31, 2020 |
3,406.67% |
| Dec 31, 2019 |
-348.91% |
| Sep 30, 2019 |
-72.22% |
| Jun 30, 2019 |
89.33% |
| Mar 31, 2019 |
100.82% |
| Dec 31, 2018 |
56.12% |
| Sep 30, 2018 |
69.30% |
| Jun 30, 2018 |
-96.60% |
| Mar 31, 2018 |
-75.81% |
| Dec 31, 2017 |
67.66% |
| Sep 30, 2017 |
-495.21% |
| Jun 30, 2017 |
67.36% |
| Mar 31, 2017 |
46.30% |
| Dec 31, 2016 |
-59.10% |
| Sep 30, 2016 |
61.73% |
| Jun 30, 2016 |
29.62% |
| Mar 31, 2016 |
10.97% |
| Dec 31, 2015 |
-137.63% |
| Sep 30, 2015 |
50.09% |
| Jun 30, 2015 |
1.83% |
| Mar 31, 2015 |
-20.75% |
| Dec 31, 2014 |
338.38% |
| Sep 30, 2014 |
-5.97% |
| Jun 30, 2014 |
1.22% |
| Mar 31, 2014 |
24.78% |
| Dec 31, 2013 |
-19.67% |
| Sep 30, 2013 |
-34.39% |
| Jun 30, 2013 |
-112.22% |
| Mar 31, 2013 |
-57.45% |
| Dec 31, 2012 |
-8.90% |
| Sep 30, 2012 |
4.05% |
| Jun 30, 2012 |
45.18% |
| Mar 31, 2012 |
34.33% |
| Dec 31, 2011 |
49.52% |
| Sep 30, 2011 |
45.84% |
| Jun 30, 2011 |
21.04% |
| Mar 31, 2011 |
-461.24% |
| Dec 31, 2010 |
-198.17% |
| Sep 30, 2010 |
-331.17% |
| Jun 30, 2010 |
-339.05% |
| Mar 31, 2010 |
-42.92% |
